DE60016566T2 - Triazolopyridazinderivate als liganden für gaba-rezeptoren - Google Patents

Triazolopyridazinderivate als liganden für gaba-rezeptoren Download PDF

Info

Publication number
DE60016566T2
DE60016566T2 DE60016566T DE60016566T DE60016566T2 DE 60016566 T2 DE60016566 T2 DE 60016566T2 DE 60016566 T DE60016566 T DE 60016566T DE 60016566 T DE60016566 T DE 60016566T DE 60016566 T2 DE60016566 T2 DE 60016566T2
Authority
DE
Germany
Prior art keywords
compound
formula
pharmaceutically acceptable
pyridazine
triazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60016566T
Other languages
German (de)
English (en)
Other versions
DE60016566D1 (de
Inventor
Robert William Harlow CARLING
Jose Luis Harlow CASTRO PINIERO
Thomas Richard Harlow LEWIS
William Kevin Harlow MOORE
Joseph Leslie Harlow STREET
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9901744.4A external-priority patent/GB9901744D0/en
Priority claimed from GBGB9901743.6A external-priority patent/GB9901743D0/en
Priority claimed from GBGB9912429.9A external-priority patent/GB9912429D0/en
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of DE60016566D1 publication Critical patent/DE60016566D1/de
Publication of DE60016566T2 publication Critical patent/DE60016566T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60016566T 1999-01-27 2000-01-19 Triazolopyridazinderivate als liganden für gaba-rezeptoren Expired - Fee Related DE60016566T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9901744.4A GB9901744D0 (en) 1999-01-27 1999-01-27 Therapeutic agents
GB9901743 1999-01-27
GB9901744 1999-01-27
GBGB9901743.6A GB9901743D0 (en) 1999-01-27 1999-01-27 Therapeutic agents
GB9912429 1999-05-27
GBGB9912429.9A GB9912429D0 (en) 1999-05-27 1999-05-27 Therapeutic agents
PCT/GB2000/000183 WO2000044752A1 (en) 1999-01-27 2000-01-19 Triazolo-pyridazine derivatives as ligands for gaba receptors

Publications (2)

Publication Number Publication Date
DE60016566D1 DE60016566D1 (de) 2005-01-13
DE60016566T2 true DE60016566T2 (de) 2005-12-15

Family

ID=27269629

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60016566T Expired - Fee Related DE60016566T2 (de) 1999-01-27 2000-01-19 Triazolopyridazinderivate als liganden für gaba-rezeptoren

Country Status (9)

Country Link
US (2) US6500828B1 (cg-RX-API-DMAC7.html)
EP (1) EP1149102B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002535407A (cg-RX-API-DMAC7.html)
AT (1) ATE284403T1 (cg-RX-API-DMAC7.html)
AU (1) AU772947B2 (cg-RX-API-DMAC7.html)
CA (1) CA2359008C (cg-RX-API-DMAC7.html)
DE (1) DE60016566T2 (cg-RX-API-DMAC7.html)
ES (1) ES2232416T3 (cg-RX-API-DMAC7.html)
WO (1) WO2000044752A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000564D0 (en) 2000-01-11 2000-03-01 Merck Sharp & Dohme Therapeutic agents
WO2002083139A1 (en) 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
US6960584B2 (en) 2001-04-10 2005-11-01 Merck & Co., Inc. Inhibitors of Akt activity
WO2002083140A1 (en) 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
DE60315876T2 (de) * 2002-11-28 2008-05-21 Neurosearch A/S Verfahren zum screening für verbindungen mit sedativer oder anxiolytischer potenz
WO2006061428A2 (en) * 2004-12-10 2006-06-15 Universität Zürich Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
HRP20140195T1 (hr) * 2008-08-29 2014-04-11 Concert Pharmaceuticals Inc. Supstituirani derivati triazolopiridazina
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2454259A1 (en) 2009-06-23 2012-05-23 Concert Pharmaceuticals Inc. Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
US8278460B2 (en) 2009-10-15 2012-10-02 Concert Pharmaceuticals, Inc. Substituted benzimidazoles
US20150099753A1 (en) * 2012-05-11 2015-04-09 Concert Pharmaceuticals Inc. Form 5 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
JP2015516440A (ja) * 2012-05-11 2015-06-11 コンサート ファーマシューティカルズ インコーポレイテッド 7−(tert−ブチル−d9)−3−(2,5−ジフルオロフェニル)−6−((1−メチル−1H−1,2,4−トリアゾール−5−イル)メトキシ)−[1,2,4]トリアゾロ[4,3−b]ピリダジンの2型多形
WO2013170241A1 (en) * 2012-05-11 2013-11-14 Concert Pharmaceuticals, Inc. Polymorphs of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolol[4,3b]pyridazine
WO2015095549A1 (en) * 2013-12-18 2015-06-25 Concert Pharmaceuticals, Inc. Dosage regimen for gabaa receptor subtype selective drug
HUE060943T2 (hu) * 2018-09-13 2023-04-28 Saniona As A gaba A receptor ligandum
AU2023258030A1 (en) * 2022-04-20 2024-10-17 Engrail Therapeutics, Inc. Gabaa receptor modulator salts, particles, and uses thereof
CN115837022B (zh) * 2023-02-20 2023-04-25 中山大学附属第八医院(深圳福田) 1,2,4三唑并4,3-b哒嗪衍生物在制备抗衰老药物中的应用
AU2024411621A1 (en) 2023-12-27 2026-06-18 Saniona A/S A gabaa receptor ligand and the use thereof in medicine, in particular in the treatment of epilepsy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0915875B1 (en) * 1996-07-25 2003-04-09 MERCK SHARP & DOHME LTD. Substituted triazolo-pyridazine derivatives as ligands for gaba receptors

Also Published As

Publication number Publication date
CA2359008A1 (en) 2000-08-03
CA2359008C (en) 2008-05-20
ES2232416T3 (es) 2005-06-01
US20030158203A1 (en) 2003-08-21
WO2000044752A1 (en) 2000-08-03
JP2002535407A (ja) 2002-10-22
ATE284403T1 (de) 2004-12-15
EP1149102A1 (en) 2001-10-31
DE60016566D1 (de) 2005-01-13
AU772947B2 (en) 2004-05-13
AU3066900A (en) 2000-08-18
US6500828B1 (en) 2002-12-31
EP1149102B1 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
DE69936998T2 (de) Pyrazolotriazinderivate als gaba-rezeptorliganden
DE60006835T2 (de) Imidazopyridinderivate als gaba rezeptor liganden
DE60012044T2 (de) Imidazopyridinderivate als liganden für gaba-rezeptoren
DE60304572T2 (de) Imidazopyridin derivate als liganden für gaba rezeptoren
DE60207416T2 (de) Imidazotriazin-derivate als gaba-rezeptor-liganden
DE60219672T2 (de) Imidazopyridine, -pyrimidine und -triazine als gaba-a alpha 5 rezeptor subtyp liganden zur verbesserung kognitiver eigenschaften
DE60021630T2 (de) Tricyclische kondensierte heterocyclische Verbindungen als CRF Antagonisten
DE69907675T2 (de) Ein substituiertes triazolo-pyridazin-derivat, davon hergestellte arzneimittel
DE60014079T2 (de) Substituierte heterocyclisch kondensierte Gammacarboline
DE60119719T2 (de) Neue aza-indolyl derivate
DE69919364T2 (de) Pyrroloindole, pyridoindole und azepinoindole als 5-ht2c agonisten
EP0059391B1 (de) Imidazodiazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE69926665T2 (de) Azolo-Pyrimidine
EP0362695B1 (de) Pyrrolocarbazol-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1149102B1 (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
EP0672666B1 (de) Imidazodiazepine
DE10327439A1 (de) Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel
DE2609486C2 (cg-RX-API-DMAC7.html)
DE60006260T2 (de) Imidazotriazinderivate als gaba rezeptor-liganden
DE3724164A1 (de) Neue 1,4-benzodiazepine, ihre herstellung und verwendung
DE60307462T2 (de) 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren
JP2002507208A (ja) Gaba−a受容体リガンドとしての三環ピラゾロ−ピリダジノン類似体
EP0100906B1 (de) Tri- und tetracyclische Imidazo(1,5-a)(1,4)Benzodiazepin-1-carbonsäurederivate
JP2002501070A (ja) Gaba受容体のリガンドとしてのトリアゾロ−ピリダジン誘導体
DE69318563T2 (de) 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATE, IHRE HERSTELLUNG UND DIE SIE ENTHALTENDEN ARZNEIMITTEL

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee